ATE363485T1 - Benzothieno(3,2-c)pyridine als alpha2- antagonisten - Google Patents

Benzothieno(3,2-c)pyridine als alpha2- antagonisten

Info

Publication number: ATE363485T1
Authority: AT; Austria
Prior art keywords: benzothieno; pyridines; alpha2 antagonists; alpha2; antagonists
Prior art date: 1998-10-06

Application number

AT99947469T

Other languages

English (en)

Inventor

Ludo Edmond Josephine Kennis

Serge Maria Aloysius Pieters

Francois Paul Bischoff

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-06

Filing date

1999-10-01

Publication date

2007-06-15

1999-10-01 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2007-06-15 Application granted granted Critical

2007-06-15 Publication of ATE363485T1 publication Critical patent/ATE363485T1/de

Links

RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1
239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT99947469T 1998-10-06 1999-10-01 Benzothieno(3,2-c)pyridine als alpha2- antagonisten ATE363485T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98203363		1998-10-06

Publications (1)

Publication Number	Publication Date
ATE363485T1 true ATE363485T1 (de)	2007-06-15

Family

ID=8234188

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99947469T ATE363485T1 (de)	1998-10-06	1999-10-01	Benzothieno(3,2-c)pyridine als alpha2- antagonisten

Country Status (27)

Country	Link
US (2)	US6426350B1 (de)
EP (1)	EP1117667B1 (de)
JP (1)	JP4580555B2 (de)
KR (1)	KR20010071828A (de)
CN (1)	CN1158287C (de)
AR (1)	AR023678A1 (de)
AT (1)	ATE363485T1 (de)
AU (1)	AU760226B2 (de)
BG (1)	BG64625B1 (de)
BR (1)	BR9913110A (de)
CA (1)	CA2346084C (de)
CZ (1)	CZ20011103A3 (de)
DE (1)	DE69936219T2 (de)
EE (1)	EE04835B1 (de)
ES (1)	ES2288025T3 (de)
HU (1)	HUP0103612A3 (de)
ID (1)	ID28280A (de)
IL (2)	IL142442A0 (de)
NO (1)	NO20011309L (de)
NZ (1)	NZ509911A (de)
PL (1)	PL347184A1 (de)
RU (1)	RU2222542C2 (de)
SK (1)	SK4312001A3 (de)
TR (1)	TR200100954T2 (de)
TW (1)	TWI251595B (de)
UA (1)	UA70334C2 (de)
WO (1)	WO2000020422A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003219029B2 (en) *	2002-03-08	2008-09-11	Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V	Use of EGFR transactivation inhibitors in human cancer
AU2003219199A1 (en) *	2002-04-03	2003-10-13	Orion Corporation	Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
AU2005233456A1 (en)	2004-04-12	2005-10-27	Taisho Pharmaceutical Co., Ltd.	Cyclic amine compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3752820A (en)	1972-03-20	1973-08-14	Colgate Palmolive Co	Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) *	1984-09-27	1987-05-22	Synthelabo	Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) *	1985-09-03	1987-08-11	Merck & Co., Inc.	Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (de)	1988-04-27	1991-03-20	Glaxo Group Limited	Laktam-Derivate
US5100891A (en) *	1991-01-18	1992-03-31	Hoechst-Roussel Pharmaceuticals Inc.	Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
GB9106179D0 (en) *	1991-03-22	1991-05-08	Sandoz Ltd	Improvements in or relating to organic compounds
ATE247114T1 (de) *	1994-09-12	2003-08-15	Lilly Co Eli	Serotonergische modulatoren
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤
UA52681C2 (uk)	1997-04-08	2003-01-15	Янссен Фармацевтика Н.В.	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

1999
- 1999-01-10 UA UA2001031998A patent/UA70334C2/uk unknown
- 1999-10-01 SK SK431-2001A patent/SK4312001A3/sk unknown
- 1999-10-01 EP EP99947469A patent/EP1117667B1/de not_active Expired - Lifetime
- 1999-10-01 BR BR9913110-2A patent/BR9913110A/pt not_active Application Discontinuation
- 1999-10-01 CZ CZ20011103A patent/CZ20011103A3/cs unknown
- 1999-10-01 KR KR1020017000400A patent/KR20010071828A/ko not_active Ceased
- 1999-10-01 PL PL99347184A patent/PL347184A1/xx not_active Application Discontinuation
- 1999-10-01 CA CA2346084A patent/CA2346084C/en not_active Expired - Fee Related
- 1999-10-01 ES ES99947469T patent/ES2288025T3/es not_active Expired - Lifetime
- 1999-10-01 DE DE69936219T patent/DE69936219T2/de not_active Expired - Lifetime
- 1999-10-01 ID IDW20010781A patent/ID28280A/id unknown
- 1999-10-01 WO PCT/EP1999/007418 patent/WO2000020422A1/en not_active Ceased
- 1999-10-01 US US09/806,432 patent/US6426350B1/en not_active Expired - Lifetime
- 1999-10-01 CN CNB998116777A patent/CN1158287C/zh not_active Expired - Fee Related
- 1999-10-01 NZ NZ509911A patent/NZ509911A/xx unknown
- 1999-10-01 TW TW088116899A patent/TWI251595B/zh not_active IP Right Cessation
- 1999-10-01 HU HU0103612A patent/HUP0103612A3/hu unknown
- 1999-10-01 RU RU2001111753/04A patent/RU2222542C2/ru not_active IP Right Cessation
- 1999-10-01 IL IL14244299A patent/IL142442A0/xx active IP Right Grant
- 1999-10-01 TR TR2001/00954T patent/TR200100954T2/xx unknown
- 1999-10-01 EE EEP200100206A patent/EE04835B1/xx not_active IP Right Cessation
- 1999-10-01 AU AU60899/99A patent/AU760226B2/en not_active Ceased
- 1999-10-01 AT AT99947469T patent/ATE363485T1/de not_active IP Right Cessation
- 1999-10-01 JP JP2000574534A patent/JP4580555B2/ja not_active Expired - Fee Related
- 1999-10-05 AR ARP990105039A patent/AR023678A1/es active IP Right Grant
2001
- 2001-03-12 BG BG105331A patent/BG64625B1/bg unknown
- 2001-03-15 NO NO20011309A patent/NO20011309L/no not_active Application Discontinuation
- 2001-04-04 IL IL142442A patent/IL142442A/en not_active IP Right Cessation
2002
- 2002-04-16 US US10/123,338 patent/US6774129B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HUP0103612A2 (hu)	2002-01-28
HK1039113A1 (en)	2002-04-12
ES2288025T3 (es)	2007-12-16
UA70334C2 (en)	2004-10-15
EE04835B1 (et)	2007-06-15
SK4312001A3 (en)	2001-12-03
DE69936219T2 (de)	2008-02-07
PL347184A1 (en)	2002-03-25
BG64625B1 (bg)	2005-09-30
AU6089999A (en)	2000-04-26
DE69936219D1 (de)	2007-07-12
EP1117667A1 (de)	2001-07-25
US6426350B1 (en)	2002-07-30
JP4580555B2 (ja)	2010-11-17
IL142442A0 (en)	2002-03-10
US20020169178A1 (en)	2002-11-14
US6774129B2 (en)	2004-08-10
TR200100954T2 (tr)	2001-12-21
KR20010071828A (ko)	2001-07-31
JP2002526546A (ja)	2002-08-20
NO20011309D0 (no)	2001-03-15
AR023678A1 (es)	2002-09-04
RU2222542C2 (ru)	2004-01-27
BR9913110A (pt)	2001-05-08
IL142442A (en)	2006-10-05
CN1321159A (zh)	2001-11-07
NO20011309L (no)	2001-03-15
CZ20011103A3 (cs)	2001-12-12
ID28280A (id)	2001-05-10
AU760226B2 (en)	2003-05-08
EP1117667B1 (de)	2007-05-30
TWI251595B (en)	2006-03-21
NZ509911A (en)	2002-09-27
CN1158287C (zh)	2004-07-21
WO2000020422A1 (en)	2000-04-13
CA2346084A1 (en)	2000-04-13
BG105331A (en)	2001-11-30
EE200100206A (et)	2002-06-17
HUP0103612A3 (en)	2003-03-28
CA2346084C (en)	2010-01-26

Legal Events

Date	Code	Title	Description
2007-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60202200D1 (de)	2005-01-13	Imidazo[1,2-a]-pyridinderivate als mglur5 antagonisten
ATE355841T1 (de)	2007-03-15	Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer
ATE249437T1 (de)	2003-09-15	Substituierte pyridine als selektive cyclooxygenase inhibitoren
ATE381565T1 (de)	2008-01-15	1,3,8-triaza-spiro 4,5 decan-4-onderivative als neurokininrezeptorantagonisten
MA24263A1 (fr)	1998-04-01	Pyridines heterocycliques fusionnes.
PT1087971E (pt)	2004-10-29	Compostos de pirrolo[2,3-d]piridina
CU23053A3 (es)	2005-06-24	1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
NZ318436A (en)	1999-02-25	Quinolein-2(1h)-one derivatives substituted with a 4-(thieno[3,2-c]pyridin-4-yl)piperazine-1-yl or 4-(4-fluorobenzoyl)piperidin-1-yl group as serotonin antagonists
DE59702034D1 (de)	2000-08-24	2-Aryl-substituierte Pyridine
FI974443A0 (fi)	1997-12-05	Heterosyklisiä rengasfuusioituneita pyrmidiinijohdannaisia
DE69714265D1 (de)	2002-08-29	Tetrahydrochinolinderivate als eaa antagonisten
ATE270294T1 (de)	2004-07-15	1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate
ID28539A (id)	2001-05-31	Imidazo (1,2a) azina bersubstitusi sebagai penghambat selektif cox-2
ATE232869T1 (de)	2003-03-15	Tricyclische delta3-piperidine als alpha2- antagonisten
ATE258935T1 (de)	2004-02-15	Furo(3,2-b)pyridine als 5-ht1f agonisten
FI930964A7 (fi)	1993-09-07	1,4-dioksino/2,3-b/pyridiinijohdannaiset
ID27845A (id)	2001-04-26	Turunan tetrahidrokuilina sebagai antagonis glisilina
DE60214408D1 (de)	2006-10-12	5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN
ATE112567T1 (de)	1994-10-15	Imidazo(4,5-c>pyridine als paf antagonisten.
ATE262904T1 (de)	2004-04-15	Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-b nzo(5,6)cyclohepta(1,2- b)pyridin
EP0505510A4 (en)	1994-08-10	Antipsychotic hexahydro-2-i(h)-indeno 1,2-c)pyridine derivatives
DE60001054D1 (de)	2003-01-30	Trizyclische pyridin n-oxide vasopressin agonisten
DE69707293D1 (de)	2001-11-15	Pyrrolo(3,2-c)chinolin-derivate
ID28280A (id)	2001-05-10	BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2
ID30349A (id)	2001-11-22	Turunan benzo (5,6) siklohepta (1,2-b) piridin untuk menghambat transferase protein farnesil